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Non-syndromic hearing loss caused by the dominant
cis mutation R75Q with the recessive mutation
V37I of the GJB2 (Connexin 26) gene
Juwon Kim1,5, Jinsei Jung2,3,5, Min Goo Lee3, Jae Young Choi2 and Kyung-A Lee4
GJB2 alleles containing two cis mutations have been rarely found in non-syndromic hearing loss. Herein, we present a Korean
patient with non-syndromic hearing loss caused by the R75Q cis mutation with V37I, which arose de novo in the father and was
inherited by the patient. Biochemical coupling and hemichannel permeability assays were performed after molecular cloning and
transfection of HEK293T cells. Student’s t-tests or analysis of variance followed by Tukey’s multiple comparison test was used
as statistical analysis. Biochemical coupling was signiﬁcantly reduced in connexin 26 (Cx26)-R75Q- and Cx26-V37I-transfected
cells, with greater extent in Cx26-R75Q and Cx26-R75Q+V37I cells. Interestingly, our patient and his father with the mutations
had more residual hearing compared with patients with the dominant mutation alone. Although the difference in hemichannel
activity between R75Q alone and R75Q in combination with V37I failed to reach signiﬁcance, it is of note that there is a
possibility that V37I located upstream of R75Q might have the ability to ameliorate R75Q expression. Our study emphasizes the
importance of cis mutations with R75Q, as the gene effect of R75Q can be modulated depending on the type of additional
mutation.
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INTRODUCTION
About 50% of autosomal recessive non-syndromic hearing loss
cases were reported to be attributed to mutations in the GJB2
gene (DFNB1; GenBank M86849, MIM121011;13q11-12),
which encodes the gap junction protein connexin 26
(Cx26).1,2 This gap junction protein assembles to form
channels to allow inorganic ions and small molecules with
molecular weights ofo1 kDa to pass between adjacent cells.3 It
is thought to have a signiﬁcant role in K+ homeostasis and
intracellular signaling within the organ of Corti.4
The genetic counseling in deaf individuals harboring GJB2
mutations should be performed with caution as interpretation
of mutations and prediction of protein function may be
complicated owing to heterogeneity of the gene expression.
The severity of hearing loss due to GJB2 is extremely variable
and sometimes cannot be predicted.5,6 The V37I mutation was
reported as a non-pathogenic variant, but recent reports
suggested that it causes a milder form of hearing loss, which
was also conﬁrmed by biochemical and electrophysiological
studies.7–10 Additional variants V27I and E114G were also
evaluated and found to cause hearing loss in certain conditions,
including VG homozygotes or a compound heterozygote with
VG.11 Interestingly, defects in hemichannel activities were less
severe when both loci were mutated, indicating that V27I
compensated for the deleterious effect of E114G. Another
interesting case showed that R75Q, a dominant GJB2 mutation,
was silenced by the cis recessive mutation c.35delG.12 Herein,
we present a Korean patient with non-syndromic hearing loss
caused by the cis R75Q mutation with V37I, which arose de
novo in the father and was inherited by the patient.
MATERIALS AND METHODS
Patients
The propositus (III-3, 16-year-old) (Figure 1a) was diagnosed with
non-syndromic hearing loss at the age of 4 and underwent cochlear
implantation. Her father (II-9, 45-year-old) had seven siblings, none
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with hearing impairment. The propositus had bilateral severe hearing
loss at the time of diagnosis, but her father showed milder presenta-
tion with profound hearing loss at higher frequencies (Figure 1b).
Residual hearing at lower frequencies was observed in both of the
patients. No dermatologic anomalies or other symptoms that have
been reported in patients with syndromic hearing loss were observed
in any of the family members including the patients.
Computed tomography of the temporal bone showed no abnormal
ﬁndings pertaining to the disease in either patient. The study
was approved by the Institutional Review Board of the Severance
Hospital (IRB#4-2010-0264) and written informed consent was
obtained from the patients before blood sampling for further
molecular analysis.
Molecular analysis
All the coding exons and intron transitions of GJB2 were ampliﬁed
by PCR and sequenced using the following primers: (forward 1)
5′-TGGTGTTTGCTCAGGAAGAG-3′, (reverse 1) 5′-TTGTGTA
GGTCCACCACAGG-3′, (forward 2) 5′-GCCTACCGGAGACATG
AGAA-3′, and (reverse 2) 5′-GGCCTACAGGGGTTTCAAAT-3′.
The SLC26A4 gene was also screened for mutations. PCR was
performed on 100 ng of genomic DNA using an AccuPower Premix
(Bioneer Co., Daejeon, Korea) under the following ampliﬁcation
conditions: 94 °C for 3min followed by 50 cycles of 94 °C for 1min,
62 °C for 10 s and 72 °C for 15 s, and ﬁnal extension was at 72 °C for
15min. The PCR products were then puriﬁed using a QIAquick Gel
Extraction Kit (Qiagen, Düsseldorf, Germany) and directly sequenced
using a cycle method with the same primers for PCR and a Big Dye
Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosys-
tems, Foster City, CA, USA) with the following conditions: 96 °C for
5min followed by 24 cycles of 96 °C for 10 s, 50 °C for 5 s and 60 °C
for 4min and ﬁnal extension at 72 °C for 5 min, in conjunction with
an ABI Prism 3500dx automated genetic analyzer (Applied Biosys-
tems). For single-strand DNA PCR, the GJB2 gene was ampliﬁed with
the primers forward 5′-ATGGATTGGGGCACGCTGC-3′ and reverse
5′-ACGTACATGAAGGCGGCTTCG-3′. The 458-bp PCR product
Figure 1 Clinical ﬁndings of a patient with non-syndromic hearing loss. (a) Pedigree and genotypes of the family. Filled symbols represent
‘affected’ individuals (□, males; ○, females; wt, wild type; N/A, not available). The propositus is indicated by an arrow. Note that
the R75Q mutation arose de novo in affected family member II-9 and was inherited by III-3. I-1 and II-7 were heterozygous for the V37I
mutation. The mutations R75Q and V37I were found to be on the same allele. (b) Pure tone audiograms of the affected members
(II-9 and III-3) of the family.
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was inserted into the T-blunt vector (SolGent, Daejeon, Korea). After
transformation, a single colony was selected, and conventional
nucleotide sequencing was performed.
Molecular cloning and transfection of HEK293T cells
HEK-293T cells obtained from the Korean Cell Line Bank (Seoul,
Korea) were maintained in Dulbecco’s modiﬁed Eagle’s medium-HG
(Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine
serum and penicillin (50 IUml-1)/streptomycin (50 μg ml-1).
The coding region of human Cx26 complementary DNA was
subcloned into the pEGFP-N1 mammalian expressible plasmid using
BamHI and EcoRI restriction sites. Plasmids expressing Cx26-V37I
and Cx26-R75Q mutant proteins were generated using a PCR-based
site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA).
The following primers were used for Cx26-V37I and Cx26-R75Q
mutagenesis, respectively: p.V37I (forward) 5′-TATGATCCT
CATTGTGGCTGCAAAGGAGGTG-3′, pV.37I (reverse) 5′-GCAGC
CACAATGAGGATCATAATGCGAAAAATG-3′, p.R75Q (forward)
5′-CCACATCCAGCTATGGGCCCTGCAGCT-3′, p.R75Q (reverse)
5′-CCATAGCTGGATGTGGGAGATGGGGAAG-3′. Plasmids were
transiently transfected into HEK-293T cells using Lipofectamine Plus
Reagent (Invitrogen).
Biochemical coupling assay and hemichannel permeability
assay
Gap junction-mediated biochemical coupling and hemichannel (con-
nexon) permeability was measured as described previously.13
Computational modeling
SWISS-MODEL was used to generate model of GJB2 tertiary structure
as previously reported.14 Cx26-R75Q and Cx26-V37I+R75Q model-
ings were based on PDB ﬁle 2ZW3 template15. Molecular graphics and
analyses were performed with the USCF Chimera package (http://
www.cgl.ucsf.edu/chimera).
Statistical analysis
The results of multiple experiments are presented as mean± s.e.m.
Statistical analysis was performed using Student’s t-tests or analysis of
variance followed by Tukey’s multiple comparison test as appropriate.
Po0.05 was considered statistically signiﬁcant (SPSS v.18.0, SPSS Inc.,
Chicago, IL, USA).
RESULTS
Molecular analysis of the patients revealed R75Q and V37I
mutations in the propositus and her father (Figure 2). No
mutation was found in her mother and other family members.
Figure 2 Sequence analysis of the GJB2 gene. (a) Mutations R75Q (c.224G4A; p.Arg75Gln) and (b) V37I (c.109G4A; p.Val37Ile) are
present in two family members, II-9 and III-3. Both family members are heterozygous for a G to A transition at position 109 and for a
transition at position 224. (c) V37I and R75Q mutations are depicted in cDNA strand of human GJB2. (d) Single-strand PCR
chromatograms of III-3 patient are presented. Note that V37I and R75Q are in the same strand.
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Her grandfather (I-1) had V37I but not R75Q mutation,
indicating that the R75Q arose de novo in the father (II-9)
and inherited to the patient III-3. To conﬁrm that
dominant mutation R75Q and recessive mutation V37I were
presented on the same allele, which is a rare event,
single-strand PCR was performed and showed that both
mutations were indeed on the same allele (Figure 2c and d).
The V37I heterozygous variation was also found in I-1
(grandfather of the propositus) and II-7 (Table 1).
To clarify the possible role of cis R75Q and V37I in vitro
functional analysis was performed. The protein expression and
cellular localization of the mutations and wild type (WT) were
determined by transfecting HEK293T cells with vectors con-
taining Cx26-WT, Cx26-V37I alone, Cx26-R75Q alone and
Cx26-R75Q+V37I (Figure 3). The wild type, as well as the
mutant R75Q, V37I, and R75Q+V37I vectors, localized to the
plasma membrane at the regions of contact between adjacent
cells and formed distinct puncta in the cytoplasm, indicating
the ability to form gap junctions at the cell junction.
To investigate the biochemical permeability of mutated gap
junction channels, cell-to-cell diffusion of propidium iodide
(PI) was measured. When PI was injected into the cell, transfer
of PI to an adjacent cell was observed in Cx26-WT cells,
whereas the Cx26-V37I alone, Cx26-R75Q alone and Cx26-
R75Q+V37I cells showed stasis of the dye in one cell
(Figure 4). Dye transfer rate was examined by measuring the
amount of dye transfer into the adjacent cells and was
categorized into fast (transferred o2min), slow (2–4min),
and no transfer groups (Table 2). The dye transfer rates of
Cx26-R75Q and Cx26-V37I+R75Q were markedly reduced
such that dye transfer was not observed in 88.2% and 83.3% of
the cells examined, respectively. In addition, the dye transfer
rate was also reduced in Cx26-V37I alone cells, although less
than that of Cx26-R75Q, with a 68.8% rate of no transfer in
these cells. The Cx26-WT cells showed efﬁcient dye transfer,
and 81.3% of the cells were fast transfer.
In the analysis of biochemical permeability of hemichannels,
~ 92.2% of cells (n= 1450) transfected with Cx26-WT exhib-
ited PI loading through hemichannels when opened by external
Figure 3 Intercellular localization of the (a) Cx26-WT, (b) Cx26-V37I, (c) Cx26-R75Q and (d) Cx26-V37I+R75Q proteins in HEK293 cells.
(Scale bar: 10 μm for all panels).
Table 1 Genotyping by single-strand PCR
Patient Detected alleles in single strand PCR
I-1 c.G109A+c.G224/c.G109+c.G224
I-2 c.G109+c.G224
II-9 c.G109A+c.G224A/c.G109+c.G224
II-10 c.G109+c.G224
III-3 c.G109A+c.G224A/c.G109+c.G224
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free Ca2+ solution (Figure 5). On the other hand, 11.2%
(n= 174) of V37I− and 3.34% (n= 36) of R75Q-transfected
cells were loaded with PI after hemichannels were opened
by Ca2+. The Ca+2-induced biochemical permeability of
Cx26-R75Q cells was reduced more than that of Cx26-V37I
cells, and the difference was statistically signiﬁcant (P= 0.03).
Co-transfection of Cx26-R75Q and Cx26-V37I had a lower
permeability than Cx26-V37I alone but slightly higher
than that of Cx26-R75Q alone (P= 0.43). The Cx26-V37I-,
Cx26-R75Q- and Cx26-V37I+R75Q-transfected cells showed
signiﬁcantly reduced PI loading compared with that of
Cx26-WT-transfected cells (Po0.01).
Finally, we performed computational tertiary structure
prediction of GJB2 mutants. 2ZW3 crystal structure was used
as template for Cx26 modeling (Figure 6). In Cx26-WT, V37
was located in transmembrane 1 and R75 in transmembrane 2.
R75 has hydrogen bonds with E47, S72 (intra-subunit) and
E187 (inter-subunit) in Cx26-WT, whereas R75Q did not have
hydrogen bonds with E47 and E187. There was no change in
the number of hydrogen bonds around R75Q even if V37I
mutation was added in Cx26-R75Q. However, the axis and
torsion of E47 and E187 were affected by the mutation of V37I.
Furthermore, the molecular distance between R75Q and S72
became much farther with the addition of V37I mutation
(2.738 Å and 3.276 Å in Cx26-R75Q and Cx26-V37I+R75Q,
respectively).
DISCUSSION
Despite recent progress in the understanding of the genetic
basis of hearing loss including the GJB2 gene, one should be
cautious in predicting the effect of a mutation on its function,
especially when both mutations are inherited in the same allele.
Mutations in cis have also been described, albeit infrequently,
Figure 4 Biochemical coupling through (a) Cx26-WT and (b–d) mutant gap junctions. The intercellular dye transfer using propidium iodide
(PI) was conducted. It is of note that, in cells expressing wild-type gap junctions, dye readily traveled through the gap junction to ﬁll the
adjacent cells, whereas mutant types showed stasis of the dye in the one cell loaded with PI.
Table 2 Percentage of propidium iodide transfer through
GJB2
Cx26 type
Propidium iodide transfer (%)
o2min 2~4min No transfer (%)
Cx26-WT 13 (82.3) 2 (12.5) 1 (6.3)
Cx26-V37I 2 (12.5) 3 (18.8) 11 (68.8)
Cx26-R75Q 0 (0) 2 (11.8) 15 (88.2)
Cx26-V37I+R75Q 0 (0) 3 (16.7) 15 (83.3)
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in other diseases vis-á-vis their impact in the development of
disease. In cystic ﬁbrosis, the ΔF508/R1158X mutation showed
pancreatic insufﬁciency explained by low stability of truncated
protein, whereas the presence of R334Q in cis with R1158X
conferred mild pancreatic symptoms.16 It was predicted that
the missense mutation R334Q in cis with R1158X somehow
stabilized truncated cystic ﬁbrosis transmembrane conductance
regulator protein.16 On the other hand, the combination of cis
p.S912L and p.G1244V ﬁbrosis transmembrane conductance
regulator protein mutations produced a severe cystic ﬁbrosis
phenotype similar to that of p.F508del homozygotes.17 In a
bilateral moderate hearing loss patient, a dominant mutation
R75Q was found in cis with the recessive mutation c.35delG,
which was thought to be the cause of the disease. However, the
family study revealed that the affected sibling of the patient did
not have this allele and indicated that R75Q was silenced by
c.35delG as c.35delG causes early termination of translation.12
Our patient had both the R75Q and V37I mutations in the
same allele, which was inherited from her father. To determine
the contribution of each mutant to this double-mutant
phenotype, we carried out an in vitro functional analysis.
The R75Q and V37I mutations did not show alteration in
the intracellular protein expression study and were localized at
the cell membrane and formed gap junctions between two
adjacent cells, indicating that the mechanism of hearing loss
due to these two mutations does not seem to be pertinent to
protein localization. However, biochemical coupling was sig-
niﬁcantly reduced in Cx26-R75Q- and Cx26-V37I-transfected
cells, with the greater extent in Cx26-R75Q- and Cx26-R75Q
+V37I-transfected cells. No difference was observed between
the cells transfected with Cx26-R75Q+V37I and Cx26-R75Q
alone, showing that V37I does not seem to impose signiﬁcant
additional effects in the gap junction function of transfer of
ions between the cells.
In the hemichannel study, the number of PI-loaded cells was
greatly reduced in Cx26-R75Q- and Cx26-V37I-transfected
cells. Although not signiﬁcant, Cx26-R75Q+V37I-transfected
cells displayed a slightly greater percentage of cells with PI
loading. These results suggest that the V37I and R75Q
Figure 6 Molecular modeling of Cx26 mutants was performed with 2ZW3 crystal structure template. (a) R75 in Cx26-WT interacts with
E47, S82 and E187. (b) R75Q in Cx26-R75Q has only hydrogen bond with S82. (c) The distance of hydrogen bond between R75Q and
S82 is farther away and the axis and torsional angle of E47 and E187 are affected by the addition of V37I mutation in Cx26-R75Q.
Figure 5 Percent of cells loaded with PI after hemichannel opening
induced by the external free Ca2+. The PI permeability was
signiﬁcantly reduced in mutant types when compared with the wild
type. Each bar represents the mean (± s.e.m.) of at least three
images of four different plates of the cells. P-value of o0.05 was
considered signiﬁcant.
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mutations signiﬁcantly reduce hemichannel activity, whereas cis
mutations slightly improve hemichannel permeability. Gluta-
mine substitution of arginine in Cx26 showed a dominant
negative effect (almost null activity) on hemichannel activity as
measured by dye loading, consistent with the dominance
inheritance of the phenotype. In addition, structural analyses
revealed that V37I could impact the structure of Cx26-R75Q
(Figure 6). R75Q mutation has dominant negative effect due to
the deterioration of hydrogen bond between neighboring
subunits of hemichannel (speciﬁcally, bond between R75 and
E147). Although the deteriorated hydrogen bond was not
rescued in the case of Cx26-V37I+R75Q, the change of tertiary
structure around R75Q such as longer distance of hydrogen
bond between E47 and S72 may affect the quaternary structure
and its function of Cx26-V37I+R75Q.
Interestingly, our patients had better residual hearing com-
pared with patients with the dominant mutation alone.
Although the difference in hemichannel activity between
R75Q alone and R75Q in combination with V37I failed to
reach signiﬁcance, it is of note that there is a possibility that
V37I located upstream of R75Q might be able to ameliorate
R75Q expression. Future experiments will have to show
whether arginine 75 is able to be substituted and whether cis
V37I somehow induces conformational change of the protein
to rescue the R75Q phenotype. In addition to a previous
study,12 our study emphasizes the importance of cis mutations
with R75Q as the gene effect of R75Q can be modulated
depending on the type of the additional mutation.
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